Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Finch Therapeutics Group Inc FNCH

Healthcare Biotechnology
Finch Therapeutics Group, Inc. is a microbiome technology company with a portfolio of intellectual property and microbiome assets. It is focused on realizing the value of its intellectual property estate and other assets, while supporting the advancement of its microbiome technology through partnerships and collaborations. It has an intellectual property estate, including more than 113 issued U... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:FNCH)

Finch Announces Reverse Stock Split of Common Stock

GlobeNewswire June 9, 2023

Finch Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Updates

GlobeNewswire May 10, 2023

Finch Therapeutics Announces Executive Leadership Transitions

GlobeNewswire April 25, 2023

Finch Therapeutics Announces Clinical Collaboration in Ulcerative Colitis with Brigham and Women's Hospital and Updates to University of Minnesota License Agreement

GlobeNewswire April 18, 2023

Finch Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Updates

GlobeNewswire March 23, 2023

Finch Therapeutics Announces Decision to Discontinue Phase 3 Trial of CP101 and Focus on Realizing the Value of Its Intellectual Property Estate and Other Assets

GlobeNewswire January 24, 2023

Finch Therapeutics Provides Corporate Updates and Reports Third Quarter 2022 Financial Results

GlobeNewswire November 10, 2022

Finch Therapeutics to Present at the Jefferies London Healthcare Conference and Evercore ISI HealthCONx Conference

GlobeNewswire November 9, 2022

Finch Therapeutics Presents PRISM-EXT Biomarker Data at ACG 2022 and Proceeds with Patient Dosing in Phase 3 Trial of CP101 in Recurrent C. Difficile Infection

GlobeNewswire October 24, 2022
View More News ››

Opinion & Analysis (NDAQ:FNCH)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:FNCH)

FNCH..Looks like a few Mooches are shopping for a thinner; )

$2.33 Might be worth a shot here at the low
Iseneschal - April 8, 2024

FNCH.....LoL lights are on but Nobody's home ; )

No stock offered......Nice Super thin deal On watch
Iseneschal - March 13, 2024

RE:FNCH..... Post RS low volume pump

I forgot to mention.... Me no position This deal has 0 Revs
Iseneschal - March 11, 2024

FNCH..... Post RS low volume pump

On watch.....for chits & giggles......$3.30
Iseneschal - March 11, 2024

FNCH ...get ready for the "rug pull"

$13.20....still halted No position
Iseneschal - June 12, 2023
View more Bullboard ››

NurExone Biologic Inc.

NurExone Biologic Inc.

NurExone Biologic Inc. is a biopharmaceutical company. The Company is developing and commercializing an exosome therapy ...
View More »